MIC
PFE icon

Mubadala Investment Company’s Pfizer PFE Stock Holding History

Mubadala Investment Company’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-444,978
Closed -$11.1M – 90
2025
Q4 		$11.1M Buy
+444,978
New +$11.2M 0.06% 19
2025
Q1 		– Sell
-144,400
Closed -$3.83M – 65
2024
Q4 		$3.83M Buy
+144,400
New +$3.92M 0.02% 22

Other funds holding PFE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Mubadala Investment Company's PFE Position: Q1 2026 in Review

Mubadala Investment Company sold out of Pfizer (PFE) in Q1 2026, closing a stake of 444,978 shares — an estimated $11.1M sold.

Mubadala Investment Company first reported a position in PFE in Q4 2024 and held it in 2 quarters. The position peaked at $11.1M in Q4 2025. 2,940 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Mubadala Investment Company reported no remaining Pfizer position as of Q1 2026 after selling out during the quarter.
  • Mubadala Investment Company sold 444,978 Pfizer shares in Q1 2026, an estimated $11.1M.
  • Mubadala Investment Company first reported a position in Pfizer in Q4 2024 and held it in 2 quarters.
  • Mubadala Investment Company's Pfizer position peaked at $11.1M in Q4 2025.
  • 2,940 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Mubadala Investment Company's 13F filing for Q1 2026, filed 15 May 2026.